Moderna (MRNA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$145.55-2.23%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MRNA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 2,228.0 | 1,944.0 | 3,236.0 | 6,848.0 | 19,263.0 | 18,471.0 | 803.0 | 60.2 | 108.4 |
| Total Revenues | — | — | — | — | 19,263.0 | 18,471.0 | 803.0 | 60.2 | 108.4 |
| Cost of Revenues | 1,707.0 | 868.0 | 1,464.0 | 4,693.0 | 5,416.0 | 2,617.0 | 8.0 | — | — |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 2,876.0 | 3,132.0 | 4,543.0 | 4,845.0 | 3,295.0 | 1,991.0 | 1,370.0 | 496.3 | 274.7 |
| Operating Income | (3,320.0) | (3,074.0) | (3,945.0) | (4,239.0) | 9,420.0 | 13,296.0 | (763.0) | (545.7) | (223.8) |
| Earnings from Continuing Operations | |||||||||
| Interest & Investment Income | 282.0 | 314.0 | 425.0 | 421.0 | 200.0 | 18.0 | 25.0 | 38.5 | 11.3 |
| Asset Writedown | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| EBT, Incl. Unusual Items | (3,087.0) | (2,768.0) | (3,607.0) | (3,942.0) | 9,575.0 | 13,285.0 | (744.5) | (514.7) | (215.2) |
| Income Tax Expense | 64.0 | 54.0 | (46.0) | 772.0 | 1,213.0 | 1,083.0 | 3.0 | (0.7) | 1.0 |
| Net Income | |||||||||
| Net Income | (3,151.0) | (2,822.0) | (3,561.0) | (4,714.0) | 8,362.0 | 12,202.0 | (747.0) | (514.0) | (216.2) |
| Per Share | |||||||||
| Basic EPS | (7.92) | (7.26) | (9.28) | (12.33) | 21.26 | 30.31 | (1.96) | — | — |
| Diluted EPS | (7.92) | (7.26) | (9.28) | (12.33) | 20.12 | 28.29 | (1.96) | — | — |
| Revenue per Share | 5.60 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 398.0 | 389.0 | 384.0 | 382.0 | 394.0 | 403.0 | 381.0 | — | — |
| Diluted Weighted Avg Shares | 398.0 | 389.0 | 384.0 | 382.0 | 416.0 | 431.0 | 381.0 | — | — |
| Supplemental | |||||||||
| EBITDA | — | (2,863.0) | (3,760.0) | (3,622.0) | 9,768.0 | 13,528.0 | (732.0) | (514.7) | (208.7) |
| EBIT | (3,320.0) | (3,074.0) | (3,945.0) | (4,239.0) | 9,420.0 | 13,296.0 | (763.0) | (545.7) | (223.8) |
| Effective Tax Rate | -2.1% | — | — | -19.6% | 12.7% | 8.2% | -0.4% | 0.1% | -0.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.